August 13, 2025 · Form 4 insider transaction
Guse Kyle bought 40,000 shares of Plus Therapeutics Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The options vest monthly over 24 months from the Grant Date in substantially equal monthly installments.